Award
National Cancer Institute 4R37CA261987-06
Targeting Wnt signaling in therapy-resistant ovarian cancer
Recipient
University of Colorado Denver, Aurora, CO, United States
Award Amount
$384,824.00
Ceiling
$384,824.00
Awarded
July 08, 2026
Identifier
4R37CA261987-06
The award supports research to overcome PARP inhibitor resistance in ovarian cancer by inhibiting Wnt signaling and modulating immune suppression, using preclinical models to inform clinical trials.
Description
This project focuses on overcoming resistance to PARP inhibitors in ovarian cancer by targeting the Wnt/β-catenin pathway and modulating the tumor immune microenvironment. It involves preclinical models and aims to inform ongoing clinical trials.